Inhibition of cytopathic effect of human immunodeficiency virus-1 by water-soluble extract of Ganoderma lucidum

Ha Won Kim, Mi Ja Shim, Eung Chil Choi, Byong Kak Kim

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

To examine components of Ganoderma lucidum for anti-human immunodeficiency virus (HIV) activity, the aqueous extracts of its basidiocarps were separated into high-molecular-weight (HMF) and low-molecular-weight (LMF) fractions. These fractions were used in XTT [2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide] antiviral assay which can quantitatively measure cytopathic effects of HIV-1 on CEM, human T lymphoblastoid cell line. The CEM cell line added with serial diluted HMF or LMF was cultured in the absence or presence of HIV-1. The results showed that the LMF of the aqueous extract strongly inhibited cytopathic effect of the target cell induced by HIV-1. When two-fold serially diluted LMF ranging from 0.97 μg/ml to 125.00 μg/ml was added to the virus-free culture system, no toxicity on the target cells was detected in all the concentrations tested. However, when it was added to the HIV-infected culture system, the viabilities of the target cell reached a plateau recovering its viabilities to 71.7% and 82.5% in experiment-1 and -2 at 15.60 μg/ml, respectively. The cell viabilities were then gradually decreased but maintained at more than 50% above 31.20 μg/ml concentration. On the contrary, HMF did not prevent any HIV-induced cytopathic effect at any concentrations tested on this cell line. From these results, negligible toxicities were observed by both HMF and LMF of C. lucidum, and recovery of cell viability in HIV infected target cell was induced only by LMF of the carpophores.

Original languageEnglish (US)
Pages (from-to)425-431
Number of pages7
JournalArchives of Pharmacal Research
Volume20
Issue number5
DOIs
StatePublished - Jan 1 1997
Externally publishedYes

Fingerprint

Reishi
Viruses
HIV-1
HIV
Cell Survival
Water
Cell Line
Cells
Fungal Fruiting Bodies
Molecular Weight
Antiviral Agents
Toxicity
Molecular weight
Assays
Recovery

Keywords

  • Anti-HIV-1 activity
  • Ganoderma lucidum
  • XTT

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery
  • Organic Chemistry

Cite this

Inhibition of cytopathic effect of human immunodeficiency virus-1 by water-soluble extract of Ganoderma lucidum. / Kim, Ha Won; Shim, Mi Ja; Choi, Eung Chil; Kim, Byong Kak.

In: Archives of Pharmacal Research, Vol. 20, No. 5, 01.01.1997, p. 425-431.

Research output: Contribution to journalArticle

@article{8f5c80c80637482daac8c7ae0b72a0f5,
title = "Inhibition of cytopathic effect of human immunodeficiency virus-1 by water-soluble extract of Ganoderma lucidum",
abstract = "To examine components of Ganoderma lucidum for anti-human immunodeficiency virus (HIV) activity, the aqueous extracts of its basidiocarps were separated into high-molecular-weight (HMF) and low-molecular-weight (LMF) fractions. These fractions were used in XTT [2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide] antiviral assay which can quantitatively measure cytopathic effects of HIV-1 on CEM, human T lymphoblastoid cell line. The CEM cell line added with serial diluted HMF or LMF was cultured in the absence or presence of HIV-1. The results showed that the LMF of the aqueous extract strongly inhibited cytopathic effect of the target cell induced by HIV-1. When two-fold serially diluted LMF ranging from 0.97 μg/ml to 125.00 μg/ml was added to the virus-free culture system, no toxicity on the target cells was detected in all the concentrations tested. However, when it was added to the HIV-infected culture system, the viabilities of the target cell reached a plateau recovering its viabilities to 71.7{\%} and 82.5{\%} in experiment-1 and -2 at 15.60 μg/ml, respectively. The cell viabilities were then gradually decreased but maintained at more than 50{\%} above 31.20 μg/ml concentration. On the contrary, HMF did not prevent any HIV-induced cytopathic effect at any concentrations tested on this cell line. From these results, negligible toxicities were observed by both HMF and LMF of C. lucidum, and recovery of cell viability in HIV infected target cell was induced only by LMF of the carpophores.",
keywords = "Anti-HIV-1 activity, Ganoderma lucidum, XTT",
author = "Kim, {Ha Won} and Shim, {Mi Ja} and Choi, {Eung Chil} and Kim, {Byong Kak}",
year = "1997",
month = "1",
day = "1",
doi = "10.1007/BF02973934",
language = "English (US)",
volume = "20",
pages = "425--431",
journal = "Archives of Pharmacal Research",
issn = "0253-6269",
publisher = "Pharmaceutical Society of Korea",
number = "5",

}

TY - JOUR

T1 - Inhibition of cytopathic effect of human immunodeficiency virus-1 by water-soluble extract of Ganoderma lucidum

AU - Kim, Ha Won

AU - Shim, Mi Ja

AU - Choi, Eung Chil

AU - Kim, Byong Kak

PY - 1997/1/1

Y1 - 1997/1/1

N2 - To examine components of Ganoderma lucidum for anti-human immunodeficiency virus (HIV) activity, the aqueous extracts of its basidiocarps were separated into high-molecular-weight (HMF) and low-molecular-weight (LMF) fractions. These fractions were used in XTT [2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide] antiviral assay which can quantitatively measure cytopathic effects of HIV-1 on CEM, human T lymphoblastoid cell line. The CEM cell line added with serial diluted HMF or LMF was cultured in the absence or presence of HIV-1. The results showed that the LMF of the aqueous extract strongly inhibited cytopathic effect of the target cell induced by HIV-1. When two-fold serially diluted LMF ranging from 0.97 μg/ml to 125.00 μg/ml was added to the virus-free culture system, no toxicity on the target cells was detected in all the concentrations tested. However, when it was added to the HIV-infected culture system, the viabilities of the target cell reached a plateau recovering its viabilities to 71.7% and 82.5% in experiment-1 and -2 at 15.60 μg/ml, respectively. The cell viabilities were then gradually decreased but maintained at more than 50% above 31.20 μg/ml concentration. On the contrary, HMF did not prevent any HIV-induced cytopathic effect at any concentrations tested on this cell line. From these results, negligible toxicities were observed by both HMF and LMF of C. lucidum, and recovery of cell viability in HIV infected target cell was induced only by LMF of the carpophores.

AB - To examine components of Ganoderma lucidum for anti-human immunodeficiency virus (HIV) activity, the aqueous extracts of its basidiocarps were separated into high-molecular-weight (HMF) and low-molecular-weight (LMF) fractions. These fractions were used in XTT [2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide] antiviral assay which can quantitatively measure cytopathic effects of HIV-1 on CEM, human T lymphoblastoid cell line. The CEM cell line added with serial diluted HMF or LMF was cultured in the absence or presence of HIV-1. The results showed that the LMF of the aqueous extract strongly inhibited cytopathic effect of the target cell induced by HIV-1. When two-fold serially diluted LMF ranging from 0.97 μg/ml to 125.00 μg/ml was added to the virus-free culture system, no toxicity on the target cells was detected in all the concentrations tested. However, when it was added to the HIV-infected culture system, the viabilities of the target cell reached a plateau recovering its viabilities to 71.7% and 82.5% in experiment-1 and -2 at 15.60 μg/ml, respectively. The cell viabilities were then gradually decreased but maintained at more than 50% above 31.20 μg/ml concentration. On the contrary, HMF did not prevent any HIV-induced cytopathic effect at any concentrations tested on this cell line. From these results, negligible toxicities were observed by both HMF and LMF of C. lucidum, and recovery of cell viability in HIV infected target cell was induced only by LMF of the carpophores.

KW - Anti-HIV-1 activity

KW - Ganoderma lucidum

KW - XTT

UR - http://www.scopus.com/inward/record.url?scp=0038634342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038634342&partnerID=8YFLogxK

U2 - 10.1007/BF02973934

DO - 10.1007/BF02973934

M3 - Article

VL - 20

SP - 425

EP - 431

JO - Archives of Pharmacal Research

JF - Archives of Pharmacal Research

SN - 0253-6269

IS - 5

ER -